Iron Horse Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$67.8K Buy
243
+104
+75% +$29.5K 0.02% 119
2025
Q1
$43.3K Sell
139
-143
-51% -$42.2K 0.01% 135
2024
Q4
$73.6K Sell
282
-7
-2% -$2.08K 0.02% 87
2024
Q3
$93K Buy
289
+1
+0.3% +$327 0.03% 71
2024
Q2
$89.9K Buy
288
+246
+586% +$72.3K 0.03% 65
2024
Q1
$11.9K Hold
42
﹤0.01% 184
2023
Q4
$12.1K Buy
42
+29
+223% +$7.9K 0.01% 167
2023
Q3
$3.49K Buy
13
+6
+86% +$1.5K ﹤0.01% 298
2023
Q2
$1.55K Hold
7
﹤0.01% 253
2023
Q1
$1.69K Sell
7
-40
-85% -$9.82K ﹤0.01% 282
2022
Q4
$12K Buy
+47
New +$12.6K 0.01% 119
2022
Q3
Sell
-47
Closed -$11K 139
2022
Q2
$11K Hold
47
0.01% 120
2022
Q1
$11K Hold
47
0.01% 125
2021
Q4
$11K Buy
+47
New +$9.92K 0.01% 115

Other funds holding AMGN

Iron Horse Wealth Management's AMGN Position: Q2 2025 in Review

Iron Horse Wealth Management increased its Amgen (AMGN) stake by 75% in Q2 2025, buying an estimated $29.5K and bringing the position to 243 shares worth $67.8K. The position accounts for 0.02% of the portfolio, ranked #119.

Iron Horse Wealth Management first reported a position in AMGN in Q4 2021 and has held it in 14 quarters since. The position peaked at $93K in Q3 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Iron Horse Wealth Management held 243 shares of Amgen worth $67.8K as of Q2 2025.
  • Iron Horse Wealth Management bought 104 Amgen shares in Q2 2025, an estimated $29.5K.
  • Amgen made up 0.02% of Iron Horse Wealth Management's portfolio in Q2 2025, its #119 holding.
  • Iron Horse Wealth Management first reported a position in Amgen in Q4 2021 and has held it in 14 quarters since.
  • Iron Horse Wealth Management's Amgen position peaked at $93K in Q3 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Iron Horse Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.